Equillium, Inc.
NASDAQ: EQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Bruce D. Steel
- Employees
- 35
- Headquarters
- La Jolla, United States
- IPO year
- 2018
- Market cap
- $101.2M
- Website
- https://equilliumbio.com
Loading EQ…
Loading profile data…Frequently asked questions about EQ
What does Equillium, Inc. (EQ) do?
Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical...
Where does EQ trade?
Equillium, Inc. (EQ) trades on the NASDAQ Global Market.
What sector is EQ in?
Equillium, Inc. (EQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Equillium, Inc.?
Bruce D. Steel is the chief executive officer of Equillium, Inc. (EQ).
Where is Equillium, Inc. headquartered?
Equillium, Inc. is headquartered in United States.
Does EQ pay a dividend?
Equillium, Inc. (EQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EQ go public?
Equillium, Inc. (EQ) completed its initial public offering in 2018.